018620 — WooGene B&G Co Balance Sheet
0.000.00%
- KR₩31bn
- KR₩88bn
- KR₩58bn
Annual balance sheet for WooGene B&G Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5,952 | 12,737 | 15,799 | 24,674 | 17,979 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,752 | 5,712 | 6,154 | 5,504 | 9,169 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 25,634 | 28,673 | 31,156 | 39,444 | 41,837 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 38,499 | 22,012 | 22,226 | 21,467 | 33,999 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 85,132 | 77,561 | 76,508 | 91,522 | 121,583 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 20,257 | 25,727 | 22,377 | 17,760 | 30,579 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 57,867 | 47,716 | 45,363 | 56,205 | 88,059 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 27,266 | 29,845 | 31,144 | 35,317 | 33,524 |
Total Liabilities & Shareholders' Equity | 85,132 | 77,561 | 76,508 | 91,522 | 121,583 |
Total Common Shares Outstanding |